Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts

PURPOSE: Clinical trials and epidemiological evidence have shown that combined estrogen/progestin hormone replacement therapy, but not estrogen therapy alone, increases breast cancer risk in post-menopausal women. Previously we have shown that natural and synthetic progestins, including the widely u...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Matthew T., Liang, Yayun, Besch-Williford, Cynthia, Goyette, Sandy, Mafuvadze, Benford, Hyder, Salman M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546074/
https://www.ncbi.nlm.nih.gov/pubmed/26312209
http://dx.doi.org/10.1186/s40064-015-1242-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546074/
https://www.ncbi.nlm.nih.gov/pubmed/26312209
http://dx.doi.org/10.1186/s40064-015-1242-x

Ejemplares similares